Tech billionaire Sean Parker - Reuters
According to Reuters, the donation is to be the largest ever for immunotherapy research, Institute for the treatment of cancer immunotherapy by Parker (Parker Institute) will include more than 40 laboratory experience and more than 300 researchers from six research centers key cancer: cancer center Memorial Sloan Kettering in New York, Stanford University school of Medicine, University of California at Los Angleles, University of California at San Francisco, China MD Anderson cancer Center in Houston, Texas and the University of Pennsylvania in Philadelphia.
In the past decades, there has been very little progress. Many billions of dollars have been poured into research and development of several new drugs but only extended survival time for patients 3-6 months
SEAN PARKER billionaire
Focused and fast
Share with Reuters about the purpose of establishing the Institute Parker, Parker billionaire - co-founder of Napster music-sharing site's first chairman Facebook - said the establishment of a research institute that would help connect "popular immediately any breakthrough research results between centers without incurring barriers (in terms of intellectual property) or administrative procedures cumbersome bureaucracy. "
Parker Institute will focus on research areas of cancer treatment with immune. Immunotherapy works on the principle of seeking to strengthen the immune system of the patient to be able to destroy cancer cells.
This therapy is considered the best today. Typically, as in the case of former US President Jimmy Carter had been treated by this method, in December last year he declared no longer find cancer cells in the body.
Parker said billionaire current immune therapy has only been seen as the ultimate solution. Patients only have access when their immune system has been destroyed fact because chemotherapy and radiotherapy.
In an interview last month, billionaire confident Parker said: "I want to put it to become the first therapy. It will change the entire cost of care and treatment thereafter. "
The type of new cancer drugs approved as Yervoy and Opdivo recently helped some patients obtain relief from the impact of disease. However, these treatments are not the first generation to be effective for everyone, and the scientific community is still a headache to find solutions to increase the effectiveness of their treatment.
Parker has identified Institute focuses on three main areas of research: change the T cells in the immune system of the patient to destroy the tumor; researching ways to help increase the adaptability of patients with immune drugs and therapeutic research is looking to add new solutions capable of attacking tumor.
Change model
Dr. Jedd Wolchok, head of the department treating tumors and therapies related to immune treatments at Sloan Kettering Cancer Center, said that the establishment of the Institute of Parker's "change model", help reduce pressure in finding research funding scientists to separate which he himself took at least 30% of working time.
According to him Jedd Wolchok, Parker Institute enhances cooperation between qualified scientists, helping them with the opportunity to access technology data processing technology as well as the latest information.
Wolchok He said: "I believe this will help us better study and research will also help to be faster."
Parker Institute also aims to ensure that all members can easily share their discoveries and share research tools, and help them facilitate the coordinated conduct of clinical trials with the data and processes are standardized implementation.
Parker tech billionaire said to maximize investment efficiency, all profits earned from the Parker Institute's research will be reinvested for research activities of the institute.
Accordingly, the inventor of the patented active researcher at the Institute of Parker will share pro rata 50-50 between the owners and the hospital.
A committee composed of members from each cancer center as well as representatives of the Parker Institute will jointly review of the licensing agreement. Jeff Blustone professor of the University of California at San Francisco (UCSF), is also the first study of immunotherapy for cancer treatment, has been appointed as president Parker Institute.
Parker Institute since you
Tech billionaire Parker said the idea of establishing his institute was piqued Parker from the case of Laura Ziskin late friend, Hollywood film producer and also the founder of the charitable organization specializing in helping raise money people with cancer, "Stand up to cancer".
Laura made his major deeper understanding of the urgent need to reform the work of Cancer Research. In 2011, Laura died of the disease and the first president of Facebook, said: "The death of Laura made me change." Thank you for leaving valuable comments
No comments:
Post a Comment